Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
June 2015 (inlife phase)
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2015
Report date:
2015

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Version / remarks:
(2009)
Qualifier:
according to guideline
Guideline:
other: OECD Guidance Document No. 39 (2009)
GLP compliance:
yes (incl. QA statement)
Test type:
traditional method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N''-hexane-1,6-diylbis[N'-(2-hydroxyethyl)-N'-methylurea]
EC Number:
253-281-9
EC Name:
N,N''-hexane-1,6-diylbis[N'-(2-hydroxyethyl)-N'-methylurea]
Cas Number:
36938-15-5
Molecular formula:
C14H30N4O4
IUPAC Name:
2-(3-{6-[3-(2-Hydroxyethyl)-3-methylureido]hexyl}-1-methylureido)ethanol
Constituent 2
Chemical structure
Reference substance name:
6-[3-(2-Hydroxyethyl)-3-methylureido]hexylamino 3-(methylamino)propionate
Molecular formula:
C14H30N4O4
IUPAC Name:
6-[3-(2-Hydroxyethyl)-3-methylureido]hexylamino 3-(methylamino)propionate
Test material form:
solid: bulk
Details on test material:
- Batch no.: EGGE 2806-1
- Currenta sample no.: 2187
Specific details on test material used for the study:
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
- Stability under test conditions: certified for the duration of the study
- Solubility and stability of the test substance in the solvent/vehicle: certified by analysis


Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Strain: Hsd Cpb:WU (SPF)
- Source: Harlan-Nederland, AD Horst, The Netherlands
- Age at study initiation: approximately 2 months
- Weight at study initiation (mean): males 187.4-191.6 g, females 172.6-182.6; at the study start the variation of individual weights did not exceed ± 10 per cent of the mean for each sex.
- Housing: Singly in conventional Makrolon® Type IIIH cages with gnawing sticks.
- Diet and water: ad libitum
- Acclimation period: at least 5 days; during this period, rats were also acclimatized to the restraining tubes.


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 40 - 60
- Air changes (per hr): approximately 10
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
other: liquid aerosol
Type of inhalation exposure:
nose only
Vehicle:
other: Lewatit© water
Mass median aerodynamic diameter (MMAD):
1.66 µm
Geometric standard deviation (GSD):
1.99
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION

- Mode of exposure: Animals were exposed to the aerosolized test item in Plexiglas exposure restrainers. Restrainers were chosen that accommodated the animals' size. These restrainers were designed so that the rat's tail remained outside the restrainer, thus restrained-induced hyperthermia can be avoided. This type of exposure principle is comparable with a directed-flow exposure design.The chambers used are commercially available (TSE, 61348 Bad Homburg) and the performance as well as their validation has been published.

- Description of apparatus: Dry conditioned air was used to generate the test item atmospheres The test atmosphere was conveyed through openings in the inner concentric cylinder of the chamber, directly towards the rats' breathing zone. This directed-flow arrangement minimizes re-breathing of exhaled test atmosphere. Each inhalation chamber segment was suitable to accommodate 20 rats at the perimeter location. All air flows were monitored and adjusted continuously by means of calibrated and computer controlled mass-flow-controllers. A digitally controlled calibration flow meter was used to monitor the accuracy of mass-flow-controller. The ratio between supply and exhaust air was selected so that 85-90% of the supplied air was extracted via the exhaust air location and, if applicable, via sampling ports. Gas scrubbing devices were used for exhaust air clean-up. The slight positive balance between the air volume supplied and extracted ensured that no passive influx of air into the exposure chamber occurred (via exposure restrainers or other apertures). The slight positive balance provides also adequate dead-space ventilation of the exposure restrainers. The pressure difference between the inner inhalation chamber and the exposure zone was 0.02 cm H20. The exposure system was accommodated in an adequately ventilated enclosure. Temperature and humidity are measured by the Data Acquisition and Control System using calibrated sensors. The sensors were located in the inhalation chamber.

- Source and rate of air: Inlet Air Flow (l/min): 15; Exhaust Air Flow (1imin): 12.8

- Method of conditioning air: Compressed air was supplied by Boge compressors and was conditioned (i.e. freed from water, dust, and oil) automatically by a BEKO RA 55 compressed air dryer. Adequate control devices were employed to
control supply pressure.

- System of generating particulates/aerosols: A modified BGI 3-nozzle Collison nebulizer (Type CN-25 MRE, BGIInc., Waltham MA, USA) was used in order to attain a high and temporally stable concentration of exposure atmospheres. The representative dispersion pressure was approximately 420-450 kPa. The Collision Nebulizer was maintained at 25°C using a thermostat.

- Method of particle size determination: The particle-size distribution was analyzed using a BERNER critical orifice cascade impactor.

- Treatment of exhaust air: The exhaust air was purified via filter systems.

- Temperature, humidity, pressure in air chamber:
Air pressure (kPa): 450 (control); 420 (test item); Rel. Humidity (mean, %): 94.5 (control); 83.4 (test item); Temperature (mean, "C): 21.4 (control); 21.9 (test item)

TEST ATMOSPHERE
- Brief description of analytical method used: The test-substance concentration was determined by gravimetric analysis (filter: glass-fiber filter, Sartorius, Gottingen, Germany; postsampling conditioning period of 30 min (at 70°C); 10 min equilibration in an exsiccator; digital balance). The integrity and stability of the aerosol generation and exposure system was measured by using a RAS-2 real-time aerosol photometer (MIE, Bedford,Massachusetts, USA). Samples were taken continuously from the vicinity of the breathing zone.

- Samples taken from breathing zone: yes

VEHICLE

- Concentration of test material in vehicle: 50% (w/v)
- Justification of choice of vehicle: To reduce viscosity and increase the maximum attainable concentration.


TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: Mass < 3 µm (%): 80.5
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 1.66/1.99

CLASS METHOD (if applicable)
- Rationale for the selection of the starting concentration:
Analytical verification of test atmosphere concentrations:
yes
Remarks:
gravimetric analysis
Duration of exposure:
4 h
Concentrations:
Target concentration: 5000 mg/m³
Analytical concentration: 3038 mg/m³ (technically maximal attainable concentration)
No. of animals per sex per dose:
5
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 2 weeks
- Frequency of observations and weighing: Bodyweights were recorded prior to exposure (day 0) and on days 1, 3, and 7, and 14. The appearance and behavior of each rat were examined carefully at least two times on the day of exposure and at least once daily thereafter.
- Necropsy of survivors performed: yes
- Other examinations performed: Reflexes were tested, based on recommendations made by Irwin (Psychopharmacologica 13, 1968, 222-257). Rectal temperatures were measured shortly after cessation of exposure (approximately within ½hour after the end of exposure) using a digital thermometer with a rectal probe for rats.
Statistics:
one-way ANOVA (vide infra) (body weight, rectal temperature)

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LC50
Effect level:
> 3 038 mg/m³ air (analytical)
Based on:
test mat.
Exp. duration:
4 h
Remarks on result:
other: technically maximal attainable concentration
Mortality:
Mortality did not occur at 3038 mg/m³.
Clinical signs:
other: Neither animals exposed to the vehicle nor animals exposed to the test item revealed any clinical symptoms.
Body weight:
Comparisons between the control and the exposure groups did not reveal significant differences in the incremental gain of body weights after exposure.
Gross pathology:
A few gray areas in the lungs of 2/5 female rats and few dark-red foci in the lungs of 2/5 male rats were found in the test item exposed animals.
Other findings:
- Rectal temperatur: Statistical comparisons between the control and the exposure groups did not reveal any significant changes in body temperature at 3038 mg/m³ compared to control animals.
- Reflex measurements: No differences between animals exposed to 3038 mg/m³ test item compared to the control group were found.

Applicant's summary and conclusion

Executive summary:

A study on the acute inhalation toxicity was conducted according to OECD TG 403 and OECD GD 39. Male and female rats were nose-only exposed to the liquid aerosol of test item at the maximal technical attainable concentration of 3038 mg/m³. Lewatit© water was used as vehicle to reduce viscosity and increase the maximum attainable concentration. The respirability of the aerosol was adequate and in compliance with test guidelines (MMAD 1.66 µm, GSD 1.99). Rats exposed to 3038 mg/m³ did neither reveal clinical symptoms, reduction in incremental body weight, changes in reflexes nor reduction in body temperature after the exposure. Four out of ten rats showed gross pathological findings in the lungs on day 14 (e.g. few gray areas, few dark-red foci). The LC50 (4 h) was thus concluded to be > 3038 mg/m³.